Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

RHIV A Pilot Study Refractory or Intolerant to Highly Active Antiretroviral Therapy (HAART) (HIV-HAART)

This study has been withdrawn prior to enrollment.
Sponsor:
Collaborator:
Therakos
Information provided by:
Atlantic Health System
ClinicalTrials.gov Identifier:
NCT00157027
First received: September 8, 2005
Last updated: January 15, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: April 2010
  Estimated Primary Completion Date: No date given